Emory Children’s Center is one of eighteen type 1 diabetes TrialNet International Clinical Centers at the forefront of type 1 diabetes research. Led by Andrew Muir, MD, the TrialNet team at Emory is dedicated to preventing type 1 diabetes and stopping disease progression by preserving insulin production before and after diagnosis.

Led by David Hansen, MD, MPH, the TrialNet team at Joslin Center at SUNY Upstate Medical University is dedicated to preventing type 1 diabetes and stopping disease progression by preserving insulin production before and after diagnosis.

Note: As a TrialNet affiliate, Joslin Center at SUNY Upstate Medical University is regionally overseen by Columbia University. If you reach out to TrialNet, you may be contacted by staff from either institution

Joslin Diabetes Center is one of eighteen Type 1 Diabetes TrialNet International Clinical Centers at the forefront of type 1 diabetes research. Led by Jason Gaglia, MD, MMSc, the TrialNet team at Joslin Diabetes Center is dedicated to preventing type 1 diabetes and stopping disease progression by preserving insulin production before and after diagnosis.

Led by Steven D. Kunkel, MD, the TrialNet team at Kadlec Medical Center Diabetes Learning Center is dedicated to preventing type 1 diabetes and stopping disease progression by preserving insulin production before and after diagnosis. 

Note: As a TrialNet affiliate, Kadlec Medical Center Diabetes Learning Center is regionally overseen by Benaroya Research Institute. If you reach out to TrialNet, you may be contacted by staff from either institution. 

Led by Rodica Busui MD, PhD, the TrialNet team at Oregon Health and Science University is dedicated to preventing type 1 diabetes and stopping disease progression by preserving insulin production before and after diagnosis.

Note: As a TrialNet affiliate, Oregon Health and Science University is regionally overseen by Benaroya Research Institute. If you reach out to TrialNet, you may be contacted by staff from either institution

Led by Christopher Kishiyama, MD, the TrialNet team at Providence Sacred Heart Medical Center is dedicated to preventing type 1 diabetes and stopping disease progression by preserving insulin production before and after diagnosis.

Note: As a TrialNet affiliate, Providence Sacred Heart Medical Center is regionally overseen by Benaroya Research Institute. If you reach out to TrialNet, you may be contacted by staff from either institution. 

Led by Associate Professor Tony Huynh, the TrialNet team at Queensland Children's Hospital is dedicated to preventing type 1 diabetes and stopping disease progression by preserving insulin production before and after diagnosis.

Note: As a TrialNet affiliate, Queensland Children's Hospital is regionally overseen by Walter and Eliza Hall Institute of Medical Research. If you reach out to TrialNet, you may be contacted by staff from either institution

Riley Hospital for Children is one of eighteen Type 1 Diabetes TrialNet International Clinical Centers at the forefront of type 1 diabetes research. Led by Principal Investigator, Linda DiMeglio, MD, the TrialNet team at the Riley's is dedicated to preventing type 1 diabetes and stopping disease progression by preserving insulin production before and after diagnosis.

Led by David Liljenquist, MD, the TrialNet team at Rocky Mountain Diabetes and Osteoporosis Center is dedicated to preventing type 1 diabetes and stopping disease progression by preserving insulin production before and after diagnosis.

Note: As a TrialNet affiliate, Rocky Mountain Diabetes and Osteoporosis Center is regionally overseen by Benaroya Research Institute. If you reach out to TrialNet, you may be contacted by staff from either institution. 

Led by Led by Rashmi Jain, MD., the TrialNet team at Sanford Children's Specialty Clinic is dedicated to preventing type 1 diabetes and stopping disease progression by preserving insulin production before and after diagnosis.